Key result
By the end of treatment, 56% of breast cancer survivors who were employed at diagnosis had returned to work, with the presence of sequelae significantly associated with continuing sick leave.
Cohort (n=96)
Yes
Breast cancer survivors face challenges returning to work primarily due to disease and treatment sequelae rather than workplace discrimination.
Answers are grounded in this paper and cite their sources.
Sequelae may prolong sick leave after breast cancer; leaves open whether targeted management improves employment outcomes.
BACKGROUND: Breast cancer survivors can have problems in returning to work. However, the importance of work to cancer survivors has until recently received little attention. AIMS: To investigate employment- and work-related disability in a cohort of breast cancer patients to identify possible discrimination and other obstacles to remaining in work. METHODS: Questionnaire study of breast cancer patients employed at diagnosis and where diagnosis had been confirmed at least 6 months before the interview. Participants completed a questionnaire concerning cancer-related symptoms and work-related factors and clinical details were obtained from their medical records. RESULTS: The study included 96 consecutive patients with breast cancer aged between 18 and 65 years. In total, 80% of patients were unable to work after diagnosis, but 56% returned to work at the end of treatment. The sequelae of the disease or its treatment and the stage of disease were independently associated with the ability to work after the end of treatment. Only one patient did not tell his/her employers and coworkers about his/her disease. In total, 29% noticed changes in their relation with co-workers and managers, usually in the sense that they tried to be helpful. None reported job discrimination. CONCLUSION: Breast cancer survivors in this study encountered some problems in returning to work, mainly linked to the sequelae of their disease and its treatment rather than to discrimination by employers or colleagues.
No takes yet. Share an insight, caveat, or question.
Villaverde et al. (2008) conducted a cohort in Breast cancer (n=96). Breast cancer and its treatment was evaluated on Return to work at the end of treatment. By the end of treatment, 56% of breast cancer survivors who were employed at diagnosis had returned to work, with the presence of sequelae significantly associated with continuing sick leave.
Synapse has enriched 10 related papers. Consider them for comparative context: